We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 583 results
  1. Swarna Bhasma Induces Antigen-Presenting Abilities of Macrophages and Helps Antigen Experienced CD4+ T Cells to Acquire Th1 Phenotypes Against Leishmania donovani Antigens

    In leishmaniasis, the protective immunity is largely mediated by proinflammatory cytokine producing abilities of T cells and an efficient parasite...

    Shashi Saini, Anshul Anand, ... Rakesh K. Singh in Biological Trace Element Research
    Article 24 April 2023
  2. Presence of anti-Leishmania infantum antibodies in sheep (Ovis aries) in Spain

    Sandflies are the primary transmission vector for Leishmania spp parasite in endemic regions. The role of other animals, different from the dog, is...

    Sergio Villanueva-Saz, María Eugenia Lebrero, ... Delia Lacasta in Veterinary Research Communications
    Article Open access 11 October 2023
  3. The Therapeutic Effects of Curcumin-coated Gold Nanoparticle Against Leishmania Major Causative Agent of Zoonotic Cutaneous Leishmaniasis (ZCL): An In Vitro and In Vivo Study

    We synthesized and characterized curcumin-coated gold nanoparticles (Cur@AuNPs) and investigated their stability, cytotoxicity, leishmanicidal...

    Seyed Mohammad Amini, Ramtin Hadighi, ... Alireza Badirzadeh in Current Microbiology
    Article 13 February 2023
  4. Proteome profiling of cutaneous leishmaniasis lesions due to dermotropic Leishmania donovani in Sri Lanka

    Background

    Characterization of the host response in cutaneous leishmaniasis (CL) through proteome profiling has gained limited insights into...

    Nuwani H. Manamperi, Nimesha Madhushani Edirisinghe, ... Nadira D. Karunaweera in Clinical Proteomics
    Article Open access 05 July 2024
  5. Engineering a multi-epitope vaccine candidate against Leishmania infantum using comprehensive Immunoinformatics methods

    Visceral leishmaniasis (VL) is a severe disease with particular endemicity in over 80 countries worldwide. There is no approved human vaccine against...

    Morteza Shams, Hassan Nourmohammadi, ... Hamid Irannejad in Biologia
    Article 29 November 2021
  6. A compared histopathological study on kidneys and eye bulbs in distinct clinical presentations of canine leishmaniasis by Leishmania infantum

    Canine leishmaniasis (CanL) caused by  Leishmania infantum commonly progresses with renal and ophthalmic lesions associated with active systemic...

    Roseclea Chagas dos Santos, Alessandra Estrela-Lima, ... Stella Maria Barrouin-Melo in Veterinary Research Communications
    Article 08 May 2024
  7. Is leishmaniasis the new emerging zoonosis in the world?

    Leishmania is a genus of parasitic protozoa that causes a disease called leishmaniasis. Leishmaniasis is transmitted to humans through the bites of...

    Esperanza Montaner-Angoiti, Lola Llobat in Veterinary Research Communications
    Article 12 July 2023
  8. Development of a chimeric protein based on a proteomic approach for the serological diagnosis of human tegumentary leishmaniasis

    Leishmania braziliensis is responsible for most cases of human tegumentary leishmaniasis (HTL) and has caused a wide range of clinical...

    Guilherme Caetano Garcia, Ana Maria Ravena Severino Carvalho, ... Daniel Menezes-Souza in Applied Microbiology and Biotechnology
    Article 25 August 2021
  9. Assessment of circulating immune complexes in canine leishmaniosis and dirofilariosis

    Canine leishmaniosis (CanL) by Leishmania infantum ( L.i .) and heartworm disease by Dirofilaria immitis ( D.i. ) are common zoonotic vector-borne...

    Roberta Iatta, Saverio Paltrinieri, ... Andrea Zatelli in Veterinary Research Communications
    Article 04 November 2022
  10. Efferocytosis: a double-edged sword in microbial immunity

    Efferocytosis is characterized as the rapid and efficient process by which dying or dead cells are removed. This type of clearance is initiated via...

    Fatemeh Mohammad-Rafiei, Fatemeh Moadab, ... Seyed Mohammad Gheibihayat in Archives of Microbiology
    Article 05 November 2023
  11. Immunoinformatics Approach to Design a Novel Subunit Vaccine Against Visceral Leishmaniasis

    Visceral leishmaniasis (VL) infection is mostly caused by Leishmania donovani and affects countries worldwide. Despite the need for a safe and...

    Alireza Lari, Niloofar Lari, Atefeh Biabangard in International Journal of Peptide Research and Therapeutics
    Article 16 December 2021
  12. Development of an immunogen containing CD4+/CD8+ T-cell epitopes for the prophylaxis of tegumentary leishmaniasis

    Abstract

    Tegumentary leishmaniasis (TL) is a disease of high severity and incidence in Brazil, and Leishmania braziliensis is its main etiological...

    Isabela de Andrade Ferraz, Ana Maria Ravena Severino Carvalho, ... Daniel Menezes-Souza in Applied Microbiology and Biotechnology
    Article 27 June 2022
  13. Heat Shock Proteins in Leishmania Parasites

    Constanze Kröber-Boncardo, Janne Grünebast, Joachim Clos in Heat Shock Proteins in Inflammatory Diseases
    Chapter 2020
  14. Origin, Phenotype, and Function of Mouse Dendritic Cell Subsets

    Dendritic cells are cells of hematopoietic origin that are specialized in antigen presentation and instruction of innate and adaptive immune...
    Dorothée Duluc, Vanja Sisirak in Dendritic Cells
    Protocol 2023
  15. Persistent T cell unresponsiveness associated with chronic visceral leishmaniasis in HIV-coinfected patients

    A large proportion of HIV-coinfected visceral leishmaniasis (VL-HIV) patients exhibit chronic disease with frequent VL recurrence. However, knowledge...

    Nicky de Vrij, Julia Pollmann, ... Wim Adriaensen in Communications Biology
    Article Open access 03 May 2024
  16. Harnessing Bioinformatic Approaches to Design Novel Multi-epitope Subunit Vaccine Against Leishmania infantum

    Kala-azar or visceral leishmaniasis (VL) is the most important vector-borne protozoan disease and a life-threatening problem in the globe due to the...

    Pejman Hashemzadeh, Vajihe Ghorbanzadeh, ... Hassan Dariushnejad in International Journal of Peptide Research and Therapeutics
    Article 17 October 2019
  17. DC-SIGNs

    Among the PRRs, the DC-SIGN (CD209) directly involves in diverse molecular events in the interaction of DCs with some pathogens. DC-SIGN as a TM...
    Chapter 2022
  18. Galectins

    Immune response is regulated by multiple pathways with activation and tolerance of immune cells. Galectins are one of the most ancient mammalian...
    Chapter 2022
  19. Non-ABO Blood Group Systems

    After the ABO blood group discovery, Karl Landsteiner and his colleagues further discovered additional markers of blood groups of MN and P, and a...
    Chapter 2024
Did you find what you were looking for? Share feedback.